Yuchen Liu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Transcription Factor

Gene Expression

Renal Cell Carcinoma

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Clinical and translational medicine

Nature chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Ziqi He, Chao Song, Sheng Li, Caitao Dong, Wenbiao Liao, Yunhe Xiong, Sixing Yang, Yuchen Liu
Development and Application of the CRISPR-dcas13d-eIF4G Translational Regulatory System to Inhibit Ferroptosis in Calcium Oxalate Crystal-Induced Kidney Injury. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (17) (2024)
Ziqi He, Chao Song, Sheng Li, Caitao Dong, Wenbiao Liao, Yunhe Xiong, Sixing Yang, Yuchen Liu
Development and Application of the CRISPR-dcas13d-eIF4G Translational Regulatory System to Inhibit Ferroptosis in Calcium Oxalate Crystal-Induced Kidney Injury. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (17) (2024)
Ziqi He, Chao Song, Sheng Li, Caitao Dong, Wenbiao Liao, Yunhe Xiong, Sixing Yang, Yuchen Liu
Development and Application of the CRISPR-dcas13d-eIF4G Translational Regulatory System to Inhibit Ferroptosis in Calcium Oxalate Crystal-Induced Kidney Injury. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (17) (2024)
Ziqi He, Chao Song, Sheng Li, Caitao Dong, Wenbiao Liao, Yunhe Xiong, Sixing Yang, Yuchen Liu
Development and Application of the CRISPR-dcas13d-eIF4G Translational Regulatory System to Inhibit Ferroptosis in Calcium Oxalate Crystal-Induced Kidney Injury. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Congcong Cao, Aolin Li, Chaojie Xu, Baorui Wu, Lin Yao, Yuchen Liu
Engineering artificial non-coding RNAs for targeted protein degradation. Nature chemical biology (2024)
Ziqi He, Chao Song, Sheng Li, Caitao Dong, Wenbiao Liao, Yunhe Xiong, Sixing Yang, Yuchen Liu
Development and Application of the CRISPR-dcas13d-eIF4G Translational Regulatory System to Inhibit Ferroptosis in Calcium Oxalate Crystal-Induced Kidney Injury. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (17) (2024)
Yonghao Zhan, Congcong Cao, Aolin Li, Hongbing Mei, Yuchen Liu
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme. Genome biology 24 (1) (2023)
Congcong Cao, Aolin Li, Chaojie Xu, Baorui Wu, Jun Liu, Yuchen Liu
Enhancement of protein translation by CRISPR/dCasRx coupled with SINEB2 repeat of noncoding RNAs. Nucleic acids research (2023)
Yonghao Zhan, Congcong Cao, Aolin Li, Hongbing Mei, Yuchen Liu
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme. Genome biology 24 (1) (2023)
Yonghao Zhan, Congcong Cao, Aolin Li, Hongbing Mei, Yuchen Liu
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme. Genome biology 24 (1) (2023)
Yonghao Zhan, Congcong Cao, Aolin Li, Hongbing Mei, Yuchen Liu
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme. Genome biology 24 (1) (2023)
Ganglin Su, Lin Yao, Xiaohong Han, Xinhui Liao, Jieqing Chen, Tao Yin, Ying Dong, Yanfeng Li, Kun Hu, Junwen Xiao, Yuchen Liu, Weiren Huang, Hongbing Mei
A synthetic targeted RNA demethylation system based on CRISPR-Cas13b inhibits bladder cancer progression. Clinical and translational medicine 12 (2) (2022)
Aolin Li, Congcong Cao, Ying Gan, Xiaofei Wang, Tianyu Wu, Quan Zhang, Yuchen Liu, Lin Yao, Qian Zhang
ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3. Clinical and translational medicine 12 (6) (2022)
Yonghao Zhan, Aolin Li, Congcong Cao, Yuchen Liu
CRISPR signal conductor 2.0 for redirecting cellular information flow. Cell discovery 8 (1) (2022)
Congcong Cao, Lin Yao, Aolin Li, Quan Zhang, Zhenan Zhang, Xiaofei Wang, Ying Gan, Yuchen Liu, Qian Zhang
A CRISPR/dCasX-mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c-MYC or activating TP53. Clinical and translational medicine 11 (9) (2022)
Yuchen Liu, Weiren Huang, Zhiming Cai
Synthesizing AND gate minigene circuits based on CRISPReader for identification of bladder cancer cells. Nature communications 11 (1) (2020)
Jing Fan, Yuchen Liu, Lisa Liu, Yikun Huang, Xuemei Li, Weiren Huang
A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy. ACS synthetic biology 9 (2) (2020)
Hengji Zhan, Qun Zhou, Qunjun Gao, Jianfa Li, Weiren Huang, Yuchen Liu
Multiplexed promoterless gene expression with CRISPReader. Genome biology 20 (1) (2019)
Yuhan Liu, Mengting Ding, Qunjun Gao, Anbang He, Yuchen Liu, Hongbing Mei
Current Advances on the Important Roles of Enhancer RNAs in Gene Regulation and Cancer. BioMed research international 2018 (2018)
Yuchen Liu, Jianfa Li, Zhicong Chen, Weiren Huang, Zhiming Cai
Synthesizing artificial devices that redirect cellular information at will. eLife 7 (2018)